We then describe studies illustrating the potential of preclinical molecular PD-L1 imaging to reveal PD-L1 biology, specifically discussing the use of preclinical imaging to monitor spatial and temporal heterogeneity of PD-L1 expression throughout tumor development and treatment regimes. The gene discussed is CD274; the disease is neoplasm.